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Summary: We evaluated an immunoturbidimetric Du Pont ACA method for the determination of IgG, IgA
and IgM in serurn. Between-day reproducibilities of the ACA assays were comparable to those of a radial
immunodiffusion, a Hyland nephelometric and a turbidimetric assay on Centrifichem 400. Correlations be-
tween results obtained by these methods were acceptable, but the results differed quantitatively. After simu-
lated recalibration based on results of control sera or patient samples, the results for IgA and IgM became
more interchangeable. IgM concentrations below 0.25 g/l, which^are important for the assessment of intra-
uterine infections, could not be quantified with the ACA. Moderate levels of haemoglobin, bilirubin or lipids
do not interfere with the ACA assays. The evaluated assays are fast and easy to use.
Prüfung von Immunoglobulin-Bestimmungen mit dem ACA III
Zusammenfassung: Eine immunturbidimetrische Methode für die Bestimmung von IgG, IgA und IgM im
Serum mit dem DuPont ACA wurde geprüft.
Die Reproduzierbarkeit der Bestimmungen mit dem ACA von Tag zu Tag war vergleichbar mit der für die
radiale Immundiffusion,'Nephelometrie (Hyland) und Turbidimetrie (Centrifichem 400). Die Korrelation
der mit diesen Methoden erhaltenen Ergebnisse war annehmbar, die Ergebnisse unterschieden sich jedoch
quantitativ. Nach simulierter Rekalibrierung anhand der Werte von Kontrollseren oder Patientenproben
wurde für die Ergebnisse von IgA- und IgM-Bestimmungen eine bessere Übereinstimmung erzielt. IgM-Kon-
zentrationen unter 0,25 g/l, wichtig für die Feststellung intrauteriner Infektionen, konnten mit dem ACA
nicht bestimmt werden. Hämoglobin, Bilirubin oder Lipide stören — soweit untersucht — die Bestimmungen
mit dem ACA nicht. Die geprüften Methoden sind schnell und einfach im Gebrauch.
Introduction
Several techniques such äs radial immunodiffusion
turbidimetry (l, 2) and nephelometry (3, 4) can be
used for the assessment of immunoglobulin concen-
trations.
Radial immunodiffusion requires an incubation time
of at least two days. Most nephelometric immunoas-
says and turbidimetric immunoassays are rather ex-
pensive, because a Standard curve is needed with
each run.
Recently, Du Pont introdticed an ACA^assay for the
assessment of immunoglobulins in serum. ACA-as-
says, like most nephelometric and turbidimetric as-
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says, are based on the reactions of antigens with spe-
cific antibodies in a polyethylene glycol 6000 solu-
tion. The light-scattering of the immunecomplexes is
measured turbidimetrically äs the difference in ab-
sorbance at 340 and 540 nm. In contrast to the
methods mentioned above, the ACA-assay is advan-
tageous in obtaining the result from a single sample
within a few minutes. We therefore evaluated the
ACA-assay and compared its reproducibility and ac-
curacy with those of commonly used assays. Special
attention was given to the determination of low IgA
and IgM concentrations, because the diagnosis of se-
lective IgA deficiency or a previous intra-uterine in-
fection by newborns requires low detcction limits of
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IgA and IgM. Furthermorc, we tcstcd haemoglobin,
bilirubin and lipids for possible interference in the
ACA-assays.
We expected that different immunoglobulin concen-
trations vvould be given by the four assays (5, 6, 7). It
would be desirable, however, to obtain directly com-
parable results when shifting from any bf the routine
methods to the ACA method. We therefore simulat-
ed a recalibration of the ACA, based on values from
control sera and from patient samples.
Materials and Methods
Methods
The ACA assays were performed on an ACA III Instrument (E. I.
Du Pont de Nemours & Co., Inc., Wilmington, U.S.A.).
Radial immunodiffusion (RIO) was performed with Partigen
plates and Standards from Behringwerke (Marburg, F.R.G.) ac-
cording to the supplief s instructions.
The nephelometric immunoassay (ΝΙΑ) was performed on a Hy-
land PDQ nephelometer, automated with the disc 120 (Hyland
Division, Travenol Laboratories, Costa Mesa, U.S.A.) accofding
to the instructions of the manufacturer. Hyland reference serum
A (lot no OA 03A001) was used s a Standard serum.
The turbidimetric immunoassay (TIA) was performed on a Cen-
trifichem 400, s described by Boigne et al. (2) with some modifi-
cations. We used antisera and buffered polyethylene glycol solu-
tion from Orion (Orion Diagnostika, Helsinki, Finland). The
Standard serum used was the same s that applied in the nephelo-
metric assay.
P a t i e n t samples
Sera from patients were collected over a period of 4 months and
immediately frozen at -70 °C.
For the comparative study, haemolytic, icteric and lipaemic sera
were excluded.
For interference studies, five specimens with varying degree of
haemolysis were prepared from clotted blood samples. The high-
est haemoglobin level was 1.5 mmol/1. Five icteric serum samples
with increasing bilirubin concentrations up to 324 μπιοΐ/ΐ were
taken from the laboratory workload. Five serum samples with vis-
ible lipaemia were selected.
For the determination of low IgM concentrations 10 cord citrate
plasmas were collected.
Q u a l i t y con t ro l samples
Five control sera were used to determine the experimental Varia-
tion of each immunoglobulin assay on the ACA: two selected pa-
tient sera (one containing a low, the other a high concentration);
the ACA calibrator of middle-range concentration; a commercial
control serum (Seronorm Protein, lot no 102, Nyegaard, Oslo,
Norway) which was also used in the other methods; and reference
serum A, the Standard of the nephelometric assay.
S ta t i s t i ca l methods
The within-day imprecisions of the five control sera were calculat-
ed from 20 duplicate results. The five within-day imprecisions,
testcd on homogeneity (BarletCs test) were pooled to obtain an
estimated within-day Standard deviation (df = degrees of free-
dom = 95) (17).
During 20 days the five control sera, mcntioned beforc, were as-
saycd cach day in duplicate. Thc bctwccn-day Standard deviation
was estimated frorn thc duplicate results of 50 patient sera (dupli-
catcs obtained on different days), and from the results of the 5
control sera. The between-day Standard deviation was tcsted
against the within-day Standard deviation (Fw/ier-test). The linear
functional relationship of the ACA assay with each of Ine three
other assays was calculated by the rnethod of least squares, cor-
rccted for experimental errors in both methods (8).
Results
The pooled within-day and between-day Standard
deviations of the ACA-assays for IgG, IgA and IgM
are given in table 1.
Tab. 1. Imprecision of the ACA immunoglobulin assays
Standard deviation
Swithin-day )
Sbeiwccn-day )
IgG
(g/l)
0.17
0.40
IgA
(g/l)
0.05
0.10
IgM
(g/D
0.03
0.06
*) swithin-day was estimated from Standard deviations of 20 dupli-
cate determinations of calibrator 3. low and high serum pools,
reference serum A and Seronorm Protein (df =95).
**) Shetwccn-day was estimated from duplicate results of 50 human
sera assayed independent on different days (df = 50).
The between-day Standard deviation for the three
assays appeared to be significantly (p < 0.05) larger
than the within-day Standard deviation.
The between-day reproducibilities of the ACA and
the three other rnethods, determined for the same
control serum, are given in table 2. Table 2 shows
that the reproducibilities for all methods were ac-
ceptable.
A low and a high polyclonal serum sample (IgG 1.57
and 24.6 g/l respectively) were mixed in 4 known
ratios. The expected concentrations were compared
with the measured concentrations (average of 5
measurements). Linear yx-regression of the mea-
Tab. 2. Between day reproducibilities of 4 different methods for
immunoglobulin assays applied to seronorm protein.
Mean ± Standard deviation
Method n IgG
(g/0
IgA
(g/0
IgM
(g/l)
Aca 20 11.1 ±0.5 2.34 ±0.13 1.25 ±0.08
RIO 20 12.5 + 0.3 2.28 ± 0.06 1.18 ±0.07
ΝΙΑ
(Hyland) 20 11.7 ±0.8 2.18 ±0.10 1.28 ±0.11
TIA
(Centrifichem) 20 11.6 ± 0.4 2.16 ± 0.04 l .24 ± 0.05
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sured on the expected concentrations gave a slope of
0.99 (s.d. 0.01) and an y-intercept of 0.05 (s.d.
0.09) g/l.
ACA-assays wcre compared with radial immunodif-
fusion, turbidimctric and nephelometric assays by
analysing 50 human scra in duplicate (on different
days). The ACA results were plotted against the re-
sults of the other methods (fig. 1).
In addition, the results from 10 sera with Iow IgA
concentrations (0.1 to 0.8 g/l) were compared. The
functional relationships were comparable to those
shown in fig. 1:
y (ACA) = 0.13 + 1.09 χ (RIO),
y (ACA) = 0.05 4- 1.14 χ (ΝΙΑ) and
y (ACA) = 0.03 + 1.17 χ (ΤΙΑ).
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Fig. 1. Graphic fepresentatioris of functional relationships between serum immunoglobulin assay results s found with ACA III (y) and
radial immunodiffusion, nephelometry (Hyland) and turbidimetry (Centrifichem) (x).
IgA (n = 50): radial immunodiffusion y = ^0.001 + 1.08x; syx = 0.18
Hyland y = -0.03 + 1.13x; syx = 0.17
Centrifichem y = -0.16 -f 1.17x; svx = 0.15
IgG (n = 50): radial immunodiffusion y = 0.17 +"θ.88χ; svx = 0.80
Hyland y = -0.67 + I.02x; syx = 0.80
Centrifichem y = 0.26 -l· 0.95x; syx = 0.64
IgM (n = 49): radial immunodiffusion y = 0.15 + 0.78x; syx = Ο.Ί6
Hyland y = 0.26 + 0.74x; syx = 0.26
Centrifichem y = 0.06 + 0.99x; svx = 0.17
• Mean of 20 results for Seronorm Protein with both methods.
* Mean of 20 results for reference serum A with both methods,
θ Mean of 20 results for ACA calibrator 3; mean of 2 results with Hyland or Centrifichem.
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To determine IgM concentrations at the lower limit
of the measurement r nge of the ACA method (0.25
g/l) and below, we increased the sensitivity by apply-
ing a 5-fold predilution instead of the usual 20-fold
dilution; the resulting IgM values showed a distinct
positive bias of about 0.1 g/l.
To test for interference by bilirubin, haemoglobin or
lipids, immunoglobulins were determined in 5 hae-
molytic, 5 icteric and 5 lipaemic sera. No significant
interference was found for IgG. The IgA assay on
the ACA was influenced only by large amounts of
haemoglobin; haemoglobin of about 1.5 mmol/1
caused a positive interference equivalent to approxi-
mately 3 g/l of IgA. The IgM assay on the ACA
tended to show a positive interference by bilirubin
and lipids, whereas haemoglobin of about 0.5
mmol/1 apparently increased the IgM concentration
by l g/l (fig. 2).
Although the correlations between the methods
were acceptable, -the results showed quantitative dif-
ferences, which preclude the possibility of transfer-
ring from one method to an other. Attempting to
solve this problem, we simulated recalibration of the
ACA. Reference serum used s a Standard in the ne-
phelometric and turbidimetric assays was also as-
sessed by the ACA and radial immunodiffusion.
Taking this reference serum s a general Standard,
we multiplied the results of the ACA by the ratio of
the reference and ACA value. Thereafter we recal-
culated the functional relationships (tab. 3).
In the same way we simulated a recalibration of the
ACA based on a control serum. The recalculated re-
lationships are also shown in table 3.
Since the simulated recalibrations did not solve the
whole problem, especially not for IgM, we also recal-
0,8 1,<6 2,4 3,2 4,Ό 4.8· 5,6 6,4 7,2
IgM (radial i m m u n o d i f f u s i o n ) [g/l]
Fig. 2. Interference by haemoglobin, bilirubin and lipids in the
ACA III immunoglobulin M assay.
Φ Results of 3 samples with haemoglobin concentrations
of about 0.2, 0.5 and 1.5 mmol/1 c using increasing in-
terference.
A Results of 2 samples with total bilirubin concentrations
of 225 and 324 μπιοΙΛ
EB Results of 2 samples with gross lipaemia.
+ Results of non-haemolytic, non^icteric or non-lipaemic
serum samples.
ibrated the ACA using the results obtained with pa-
tient samples: we divided 50 samples into equal
groups, then calculated the functional relationships
between the ACA and the other methods for the re-
sults obtained with the samples of the first group. We
corrected the ACA results of the samples m the se-
cond group for the calculated slope of the functional
relationship. Thereafter we recalculated the func-
tional relationships for the samples of the second
group (tab. 3).
Tab. 3. The effect of the ACA calibration on the calculated functional relationships. In calculating the functional relationships, the
values obtained with radial immunodiffusion, nephelometric (Hyland) or turbidimetric assay (Centrifichem) were kept constant,
and the y-values obtained with the ACA assays were corrected by a factor derived from the results of reference serum, control
serum or patient samples.
Method
X
IgG
RIO
ΝΙΑ
TIA
IgA
RID
ΝΙΑ
TIA
IgM
RID
ΝΙΑ
TIA
ACA-calibrators
0.17 +0.88x
-0.67 + 1.02x
0.26 +0.95x
-0.001 + l.OSx
-0.03 + 1.13x
-0.16 + 1.17x
0.15 + 0.78x
0.26 + 0.74x
0.06 + 0.99x
Reference serum
(Hyland)
0.05 + 1.05x
-0.60+l.lOx
0.81 + 1.01x
-0.02 + 1.02x
-0.03 + 1.04x
-0.02+ 1.08x
0.16 + 0.67x
0.31 + 0.73x
0.06+l.Olx
Control serum
Seronorm Protein
0.05+ 1.04x
-0.57+ 1.07x
0.78+ l .Olx
-0.02+ l.OSx
-0.03 + 1.06x
-0.02+ l.OSx
0.17 + 0.79x
0.34 + O.SOx
0.09+ 1.06x
Patient
samples
-0.39 +
-1.44 +
-0.44 +
-0.03 +
-0.02 +
-0'02 +
0.36 +
0.03 +
0.26 +
.06x
.l lx
.10x
.04x
.02x
.02x
.03x
.OOx
.05x
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Discussion
The reproducibility of the ACA was comparable to
those of the other methods (tab. 2). The experimen-
tal error of a single measufement was almost entirely
determined by the between-day Variation of the iri-
strument. Variation due to predilution errors ap-
peared to be relatively smalt.
Similarity between the ACA calibrators and human
serum, tested in the IgG-assay, was quite satisfacto-
ry. We did not test the similarity between the cali-
brators and monoclonal immunoglobulins, since it
can be anticipated from results obtained with the
other methods that some of those would behave sim-
ilarly and some would not (9, 10, 11).
The ränge of the ACA assay, from the lowest to the
highest calibrator» was sufficient to meet general
clinical requirements: for IgG from 1.0 to 60 g/l and
for IgA and IgM from 0.25 to 15 g/l. In exceptional
cases, a reliable determination of low IgA or IgM
levels is clinically obligatory. In the low IgA ränge
(0.1 to 0.8 g/l) the same relationships between the
ACA and the other methods afe found, but none of
the methods tested would be sensitive enough to de-
tect IgA-deficieiicy. The same holds for the determi-
nation of immunoglobülin concentrations in cere-
brospinal fluid. In such cases more sensitive meth-
ods, i.e. radioimmunoassay or haemagglutination
should be applied (12). The üpper reference limit of
the IgM concentration in serum of newborns is about
0.20 g/l. An IgM coneentration above this limit can
be an indication of intra-uterine infection. Because
the lower limit of the ACA method is 0.25 g/l, we
increased the sensitivity of the IgM assay by applying
a 5-fold predilution. This approach cannot be re-
commended, however, because it resülted in a posi-
tive biäs of 0.1 g/l.
Interference by haemoglobin, bilirubin or lipids in
the ACA assays was related to the sample size re-
quired: 320 for IgM, 100 for IgA and 80 for
IgG. This effect might be explained from the bichro-
matic measurement on the ACA. The turbidity was
measured äs the difference in äbsorbances at 340
and 540 nm. As a haemoglobin'concentration of 0.5
mmol/1 also causes a different absorbance at these
two wavelengths, apparently higher IgM results were
obtained (fig. 2). Therefore we recommend that vis-
ibly lipaemic, icteric or haemolytic samples should
be excluded from determination of immunoglobul-
ins, especially IgM on the ACA.
Although the correlations between the results of the
different methods compared were acceptable, quan-
titative differences in immunoglobülin coneentra-
tions were found. These differences are easily as-
cribed to the Standards used (13). To test this as-
sumption, we simulated recalibrations of the ACA
on a general Standard and a commonly used control
serum. From table 3 it is obvious that the recalculat-
ed functional relationships were improved for IgG
and IgA, but not for IgM. Thus the differences in the
IgM results cannot be ascribed to the Standards
alone. Other possible causes, mentioned in the liter-
ature, are the use of different antisera, diluents con-
taining various amounts of polyethylene glycol (14)
or simply the different measuring principles of the
methods (15, 16).
The reaction conditions, which can influence the re-
sults, are inherent to the method applied in the indi-
vidual laboratory. If a laboratory used several meth-
ods, it might not be sufficient to use the same Stand-
ard and antiserum. By doing this in the present
study, we did not obtain the same results for IgM by
the turbidimetric assay (Centrifichem) and the ne-
phelometric assay (Hyland). Therefore, we strongly
recommeYid calibration of the ACA (or any other
method) with patient samples. Although functional
relationships of IgA and IgG did not improve very
fnuch or even became worse (almost certainly due to
statistical Variation of the results), IgM results ob-
tained in this way became interchangeable.
After calibration, the ACA assays of immunoglobul-
ins are easy to perform over a wide clinical ränge,
except for low IgA and IgM concentrations. We re-
commend, however, that a filter balance be per-
formed before determining the immunoglobülin
concentrations on the ACA, because the immuno-
globülin assay on the ACA appeared to be more sen-
sitive to errors in the filter ränge of the Instrument
than any of the other assays on the ACA.
The ACA assays present a good alternative for the
assessment of the immunoglobulins in laboratories
with a relatively small work load, and for emergency
determinations.
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